Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Scotts Miracle-Gro Backs FY12 Adj. EPS Outlook - Quick Facts

RELATED NEWS
Trade SMG now with 
8/10/2012 4:09 PM ET

The Scotts Miracle-Gro Company (SMG: Quote) announced that it still expects its fiscal 2012 adjusted earnings per share of about $2.00.

Analysts now expect earnings of $2.44 per share for fiscal 2012.

The company anticipates an operating loss in the fourth quarter which will translate into an adjusted loss per share closer to $0.60 per share.

Click here to receive FREE breaking news email alerts for The Scotts Miracle-Gro Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
A leading indicator of Chinese economic activity rose marginally in May and at a slower pace than a month earlier, suggesting more sluggish growth for the overall economy in the months ahead. The Conference Board said that its leading economic indicator rose 0.3 percent month-on-month in May, slower than a 1.5 percent increase in April. Only three of the six components contributed positively. While lingering worries about the outlook for the Federal Reserve's stimulus program generated some selling pressure in afternoon trading on Monday, stocks managed to end the day mostly higher after seeing an early rally on the heels of some upbeat economic data. The major averages finished the session well off their best levels of the day but still posted strong gains. In an apparent backlash from the numerous scandals facing the administration, the results of a new CNN/ORC International survey released Monday showed a sharp drop in President Barack Obama's approval rating. The poll found that 45 percent of Americans approve of the way Obama is handling his job as president, down from 53 percent in a poll conducted last month.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.